1. Home
  2. RGEN vs TECH Comparison

RGEN vs TECH Comparison

Compare RGEN & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$156.66

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$58.68

Market Cap

9.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
TECH
Founded
1981
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
9.5B
IPO Year
N/A
1989

Fundamental Metrics

Financial Performance
Metric
RGEN
TECH
Price
$156.66
$58.68
Analyst Decision
Buy
Strong Buy
Analyst Count
10
14
Target Price
$170.90
$71.23
AVG Volume (30 Days)
724.0K
1.8M
Earning Date
10-28-2025
11-05-2025
Dividend Yield
N/A
0.55%
EPS Growth
N/A
N/A
EPS
0.03
0.49
Revenue
$707,890,000.00
$1,216,732,000.00
Revenue This Year
$17.84
$2.33
Revenue Next Year
$12.57
$7.05
P/E Ratio
$5,097.58
$120.21
Revenue Growth
11.74
3.85
52 Week Low
$102.97
$46.01
52 Week High
$182.52
$79.28

Technical Indicators

Market Signals
Indicator
RGEN
TECH
Relative Strength Index (RSI) 47.50 41.76
Support Level $160.11 $58.75
Resistance Level $165.02 $61.20
Average True Range (ATR) 4.97 2.02
MACD -1.27 -0.49
Stochastic Oscillator 7.12 2.94

Price Performance

Historical Comparison
RGEN
TECH

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: